The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis

ConditionPneumatosis Cystoides Intestinalis

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-100

SponsorShowa Inan General Hospital

About this trial

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.

Eligibility criteria

Qualifiers

typical findings of PCI on colonoscopy; Line or pebble like sessile cysts are distributed around the colon with normal overlying mucosa

Disqualifiers

patients can not take Keishi-ka-shakuyaku-daio-to（TJ-134）

Trial design

Treatments tested in this trial

Japanese traditional medicine group

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Showa Inan General Hospital

Lead sponsor

Source ClinicalTrials.gov